Abstract Insights into the mechanisms by which key factors stimulate cell growth under androgen-depleted conditions is a premise to the development of effective treatments with clinically significant activity in patients with castration-resistant prostate cancer (CRPC).
Introduction 1
Worldwide, prostate cancer (PCa) is the most frequently diagnosed male cancer. 2
About one-fourth of PCa patients eventually die from this disease. Because androgen 3 receptor (AR) signaling is crucial for the development and maintenance of male 4 reproductive organs including the prostate gland, men with PCa that has disseminated 5 distantly usually respond well to androgen deprivation therapy (ADT) (either alone or in 6 combination with chemotherapy). However, despite initial response rates of ~80 to 90%, 7 nearly all PCa patients eventually develop progressive disease following ADT. This is 8 referred to as castration-resistant prostate cancer (CRPC), an incurable stage in which 9 ~90% of patients develop metastases with the highest mortality rate (Ferraldeschi, et al. by CRPC to expand our understanding of its role in metabolism regulation. 33
Through a combination of animal models, genetic tools, and pharmacological means, 34
we have uncovered a mechanistic role, reported here, for KLF14 in regulating the 35 antioxidant response in CRPC by modulation of heme oxygenase-1 (HO-1) expression. 36
Furthermore, we provide the functional evidence that in vivo administration of a 37 pharmacological inhibitor of HO-1 could attenuate castration-resistant PCa progression. 38
Overall, these findings demonstrate molecular mechanisms by which the KLF14/HO-1 39
cascade could serve as a promising therapeutic target for CRPC. 40 sacrificed and the HO-1 activity in tumor xenografts were assayed as described below. 167
Materials and methods
Determination of HO-1 activity
168
Tumor xenografts were homogenized in ice-cold homogenate buffer (20 mM PBS 169 buffer, 250 mM sucrose, 2 mM EDTA, 2 mM phenylmethylsulfonyl fluoride, and 10 µg/ml 170 leupeptin) as described elsewhere (Araujo, et al. 2013 ). After centrifuge, the resultant 171 supernatant was collected and subjected to the measurement of HO-1 activity using 172 GraphPad Software Inc.) followed by Tukey post-hoc analyses. Results are presented as 178 mean ± SEM and P < 0.05 was considered statistically significant. 179
Results

180
KLF14 upregulation is associated with the pathogenesis of CRPC
181
The present study was initially designed to uncover novel mechanisms underlying the time-dependent manner, regardless of cell types ( Fig. 2A-2D with Ctrl shRNA or cells cultured in normal medium (Fig. 3C ). Subsequent ELISA methods 232 revealed that KLF14 knockdown in CWR-R1 and DU145 cells led to notable increase of 233 apoptosis in the presence of FBS-CS culture (Fig. 3D) . Consistently, lower colony 234 formation efficiency was after FBS-CS incubation in CWR-R1 and DU145 cells stably 235 transfected with KLF14 shRNA (Fig. 3E ). Such growth inhibition by KLF14 knockdown 236 was also observed in xenograft models in castrated immunodeficient mice (Fig. 3F ). The 237 above-mentioned phenotype was further verified in and DU145 cells (Fig. 3G-3L pcDNA3.1+-DDK-KLF14 in LNCaP cells (Fig. 4A ) and then cultured these cells in medium 245
containing FBS-CS. FBS-CS-induced growth inhibition was significantly attenuated in 246
LNCaP/DDK-KLF14 cells compared with the pcDNA3.1+ vector-transfected cells (Fig. 4B) . 247
LNCaP/DDK-KLF14 cells (Fig. 4C) . In agreement, the colony formation efficiency (Fig. 4D)  249 and formation of xenograft tumors in castrated immunodeficient mice (Fig. 4E) (Bae, et al. 2004 ). Interestingly, ectopic KLF14 266 overexpression led to more paraquat resistance in LNCaP cells (Fig. 5E ), whereas KLF14 267 inhibition caused a significant reduction in cell viability in paraquat-treated DU145 cells 268 (Fig. 5F) dose-dependent shift in the redox state to increased GSSG and decreased GSH levels. 280
Contrarily, pcDNA3.1+-DDK-KLF14/LNCaP cells were able to maintain significantly higher 281 ratios of GSH/GSSG over a wide range of H 2 O 2 doses (Fig. 5H) , indicating that KLF14 282 may enhance the antioxidant response upon oxidative stress. 283 KLF14 regulates HO-1 expression at the transcriptional level 284
To dissect the molecular mechanisms underlying the promoting effect of KLF14 on 285 the antioxidant response, we examined the expression levels of a range of antioxidant 286 genes in pcDNA3.1+-DDK-KLF14/LNCaP cells using RT-qPCR. These experiments 287
revealed that KLF14 induced a ~5.3-fold increase in expression of HMOX1 (Fig. 6A) , the 288 gene encoding heme oxygenase 1 (HO-1), a rate-limiting enzyme conferring 289 cytoprotection against oxidative stress (Nitti, et al. 2017). We confirmed the parallel 290 upregulation of KLF14 and HO-1 expression in the CRPC patient-derived xenograft model 291 using immunoblotting analysis (Fig. 6B ). More importantly, KLF14 overexpression 292 resulted in a significant induction of HO-1 expression, at both translational (Fig. 6C) and 293 transcriptional levels (Fig. 6D) . These results led us to investigate whether KLF14 294 functions as a transcriptional regulator of HMOX1. As revealed by luciferase assays, 295 transfection with pcDNA3.1+-DDK-KLF14 significantly increased the HMOX1 reporter 296 activity relative to control vector. This stimulatory effect was notably amplified by 297 co-incubation with H 2 O 2 or diamide. In good contrast, simultaneous treatment with 298 diphenyleneiodonium chloride successfully abolished diamide-enhanced HMOX1 299 trans-activation by KLF14 (Fig. 6E) . Interestingly, subsequent evidence derived from 300 analysis of the 5′ flanking regions of human HMOX1 identified four sequences containing 301 the conserved binding site of KLF14 (CACCC box, Fig. 6F ). We then tested the 302 hypothesis that KLF14 functions as a regulator of the putative binding sites in the HMOX1 303
promoter. ChIP assay revealed that KLF14 could bind the promoter region that harbors 304 the proximal CACCC box (-645/-641) (Fig. 6G) -645/-641 site greatly reduced promoter activity (Fig. 6H and 6I ). To extend our 309 mechanistic understanding of how H 2 O 2 regulates the transcription of HMOX1 through 310 KLF14, we performed a double ChIP assay. Initial ChIP was done with anti-MTA2 311 antibody to immunoprecipitate the KLF14-bound DNA sequences, and the second ChIP 312 was done with the anti-CBP or anti-p300 antibodies. We observed simultaneous 313 co-association of KLF14 and CBP or p300 with the HMOX1 chromatin, and this 314 recruitment was substantially augmented when H 2 O 2 was added (Fig. 6J) . Thus, together, 315 these data demonstrate that KLF14 transcription factor is involved in the positive 316 regulation of HMOX1 transcription. 317
HO-1 inhibition counteracts KLF14-induced castration-resistance 318
The preceding data have shown that upregulation of KLF14 expression induces HO-1 319 expression and resistance to oxidative stress, underscoring a fundamental role for KLF14 320 in the regulation of the antioxidant response under androgen-depleted conditions. In his 321 regard, we finally initiated efforts toward evaluating the effect of HO-1 inhibition on 322 KLF14-induced castration-resistance. At the in vitro level, we probed the role of KLF14 323
targeting HO-1 in LNCaP cells stably expressing pcDNA3.1+-DDK-KLF14. The 324 transfection efficiency of HMOX1 shRNA in DDK-KLF14/LNCaP cells was over 80% but 325 HO-1 silence exerted no effects on KLF14 expression level (Fig. 7A) . Worthy to note, 326 HO-1 knockdown successfully abolished KLF14 overexpression-induced cell proliferation 327 (Fig. 7B ) and compromised KLF14-stimulated colony formation efficiency under 328 androgen-depleted conditions (Fig. 7C) . We then tried to solid this observation by 329 examining the in vivo antitumor effect of ZnPPIX, a specific inhibitor of HO-1 (Fig. 7D) 
330
(Hirai et al. 2007). I.P. injection of ZnPPIX (30 mg/kg; once a day) suppressed the 331 of tumor development (Fig. 7E) , which correlated well to a decrease of HO-1 activity in 333 xenograft tumors (Fig. 7F) . Notably, in vivo application of ZnPPIX effectively suppressed 334 HO-1 expression but exerted no effects on KLF14 level in xenograft tumors 335 (Supplementary Fig. 2) and as a modifier of the oxidative stress signaling in conferring an optimal adaptive 423 mechanism during the pathogenesis of CRPC. 424
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